EYPT | EyePoint Pharmaceuticals, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	355.18 Million	180.35 Million	263.37 Million	91.71 Million	73.32 Million	71.67 Million
Total Current Assets	344.8 Million	172.8 Million	237.74 Million	63.11 Million	42.06 Million	39.9 Million
Cash And Short Term Investments	331.05 Million	144.56 Million	211.55 Million	44.9 Million	22.21 Million	38.77 Million
Cash and Cash Equivalents	281.26 Million	95.63 Million	178.59 Million	44.9 Million	22.21 Million	38.77 Million
Short Term Investments	49.78 Million	48.92 Million	32.96 Million	-	-	-
Net Receivables	805 Thousand	15.5 Million	18.35 Million	9.45 Million	11.72 Million	353 Thousand
Inventory	3.9 Million	2.88 Million	3.61 Million	5.33 Million	2.13 Million	-353 Thousand
Other Current Assets	9.03 Million	9.85 Million	4.21 Million	3.41 Million	8.13 Million	1.13 Million
Total Non-Current Assets	10.38 Million	7.54 Million	25.62 Million	28.59 Million	31.25 Million	31.76 Million
Net PPE	10.23 Million	6.03 Million	2.25 Million	3.24 Million	3.07 Million	253 Thousand
Good Will And Intangible Assets	-	-	22.74 Million	25.2 Million	27.66 Million	31.35 Million
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	22.74 Million	25.2 Million	27.66 Million	31.35 Million
Long-Term Investments	150 Thousand	150 Thousand	150 Thousand	150 Thousand	150 Thousand	150 Thousand
Tax Assets	-	-	-150 Thousand	-150 Thousand	-150 Thousand	-150 Thousand
Other Non Current Assets	-	1.36 Million	626 Thousand	150 Thousand	507 Thousand	150 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	88.86 Million	83.98 Million	78.99 Million	73.17 Million	64.99 Million	59.98 Million
Total Current Liabilities	63.26 Million	34.53 Million	23.65 Million	14.88 Million	11.87 Million	21.66 Million
Account Payables	6.5 Million	5.91 Million	7.38 Million	4.81 Million	11.37 Million	6.66 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	563 Thousand	10.47 Million	782 Thousand	8.44 Million	481 Thousand	-30 Thousand
Deferred Revenue	38.59 Million	1.2 Million	1.06 Million	945 Thousand	15 Thousand	30 Thousand
Other Current Liabilities	17.6 Million	16.93 Million	14.42 Million	687 Thousand	-	15 Million
Total Non Current Liabilities	25.59 Million	49.45 Million	55.33 Million	58.28 Million	53.12 Million	38.32 Million
Long-Term Debt	4.9 Million	35.29 Million	38.42 Million	40.3 Million	50.12 Million	17.3 Million
Deferred Revenue Non Current	20.69 Million	13.55 Million	14.56 Million	15.61 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	20.69 Million	600 Thousand	2.35 Million	2.36 Million	3 Million	21.01 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	266.32 Million	96.36 Million	184.38 Million	18.54 Million	8.33 Million	11.68 Million
Stock Holders Equity	266.32 Million	96.36 Million	184.38 Million	18.54 Million	8.33 Million	11.68 Million
Common Stock	49 Thousand	766.93 Million	752.63 Million	528.38 Million	472.77 Million	374.84 Million
Retained Earnings	-742.14 Million	-671.35 Million	-569.09 Million	-510.68 Million	-465.28 Million	-363.99 Million
Accumulated other comprehensive income	864 Thousand	786 Thousand	841 Thousand	841 Thousand	840 Thousand	838 Thousand
Common Stock Equity	266.32 Million	96.36 Million	184.38 Million	18.54 Million	8.33 Million	11.68 Million
Capital Lease Obligation	4.9 Million	5.98 Million	1.86 Million	2.33 Million	3.37 Million	-
Total Investments	49.93 Million	48.92 Million	32.96 Million	150 Thousand	150 Thousand	150 Thousand
Total Debt	5.46 Million	45.76 Million	38.42 Million	40.3 Million	50.6 Million	17.3 Million
Net Debt	-275.79 Million	-49.86 Million	-140.17 Million	-4.6 Million	28.38 Million	-21.46 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	324.24 Million	329.24 Million	355.18 Million	355.18 Million	160.04 Million	175.65 Million
Total Current Assets	294.93 Million	317.7 Million	344.8 Million	344.8 Million	150.16 Million	167.11 Million
Cash And Short Term Investments	280.24 Million	299.34 Million	331.05 Million	331.05 Million	136.01 Million	142.53 Million
Cash and Cash Equivalents	90.76 Million	271.01 Million	281.26 Million	281.26 Million	133.03 Million	139.59 Million
Short Term Investments	189.47 Million	28.33 Million	49.78 Million	49.78 Million	2.97 Million	2.93 Million
Net Receivables	1.37 Million	3.01 Million	805 Thousand	805 Thousand	483 Thousand	10.95 Million
Inventory	3.67 Million	4.25 Million	3.9 Million	3.9 Million	4.57 Million	4.26 Million
Other Current Assets	9.63 Million	11.08 Million	9.03 Million	9.03 Million	9.09 Million	9.37 Million
Total Non-Current Assets	29.31 Million	11.53 Million	10.38 Million	10.38 Million	9.88 Million	8.53 Million
Net PPE	29.16 Million	11.38 Million	10.23 Million	10.23 Million	5.25 Million	5.51 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	150 Thousand	150 Thousand	150 Thousand	150 Thousand	150 Thousand	150 Thousand
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	-	-	-	-	4.48 Million	2.87 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	95.94 Million	79.31 Million	88.86 Million	88.86 Million	101.42 Million	118.39 Million
Total Current Liabilities	62.1 Million	62.58 Million	63.26 Million	63.26 Million	63.89 Million	68.91 Million
Account Payables	14.29 Million	7.08 Million	6.5 Million	6.5 Million	9.58 Million	10.71 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	1.13 Million	1.09 Million	563 Thousand	563 Thousand	13.41 Million	970 Thousand
Deferred Revenue	33.33 Million	38.37 Million	38.59 Million	38.59 Million	39.84 Million	42.08 Million
Other Current Liabilities	13.34 Million	16.02 Million	17.6 Million	17.6 Million	1.05 Million	15.14 Million
Total Non Current Liabilities	33.84 Million	16.73 Million	25.59 Million	25.59 Million	37.52 Million	49.47 Million
Long-Term Debt	22.16 Million	4.62 Million	4.9 Million	4.9 Million	5.18 Million	5.45 Million
Deferred Revenue Non Current	11.67 Million	12.1 Million	20.69 Million	20.69 Million	32.34 Million	44.02 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	11.67 Million	12.1 Million	20.69 Million	20.69 Million	32.34 Million	44.02 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	228.3 Million	249.93 Million	266.32 Million	266.32 Million	58.62 Million	57.26 Million
Stock Holders Equity	228.3 Million	249.93 Million	266.32 Million	266.32 Million	58.62 Million	57.26 Million
Common Stock	52 Thousand	50 Thousand	49 Thousand	49 Thousand	785.82 Million	771.85 Million
Retained Earnings	-802.25 Million	-771.43 Million	-742.14 Million	-742.14 Million	-728.04 Million	-715.43 Million
Accumulated other comprehensive income	792 Thousand	836 Thousand	864 Thousand	864 Thousand	841 Thousand	842 Thousand
Common Stock Equity	228.3 Million	249.93 Million	266.32 Million	266.32 Million	58.62 Million	57.26 Million
Capital Lease Obligation	22.16 Million	4.62 Million	4.9 Million	4.9 Million	5.18 Million	5.45 Million
Total Investments	189.62 Million	28.48 Million	49.93 Million	49.93 Million	2.97 Million	2.93 Million
Total Debt	23.29 Million	5.72 Million	5.46 Million	5.46 Million	5.18 Million	5.45 Million
Net Debt	-67.47 Million	-265.29 Million	-275.79 Million	-275.79 Million	-127.85 Million	-134.14 Million

Balance Sheet Charts

City Steel Public Company Limited

CITY

Full Analysis

Annual Balance Sheets
Zomato Limited

ZOMATO

Full Analysis

Annual Balance Sheets
BioRem Inc.

BIRMF

Full Analysis

Annual Balance Sheets
Transgene SA

TRGNF

Full Analysis

Annual Balance Sheets
AEW UK REIT plc

AEWU

Full Analysis

Annual Balance Sheets
Crown LNG Holdings Limited

CGBS

Full Analysis

Annual Balance Sheets

Global Stocks Search

EyePoint Pharmaceuticals, Inc. (EYPT)

Annual Balance Sheets

Balance Sheet Charts

City Steel Public Company Limited

Zomato Limited

BioRem Inc.

Transgene SA

AEW UK REIT plc

Crown LNG Holdings Limited